The role of the innovation-based pharmaceutical industry in international drug information communication.

L C Hoff
{"title":"The role of the innovation-based pharmaceutical industry in international drug information communication.","authors":"L C Hoff","doi":"10.1177/009286158301700407","DOIUrl":null,"url":null,"abstract":"<p><p>The ultimate responsibility and social contribution of the innovation-based pharmaceutical industry is to discover, develop, and provide products that contribute to improved health care. Achievement of this objective is dependent upon effective communication of accurate and comprehensive information about our products. This is a unique role which the research-based segment of the industry performs well and must be allowed to continue to perform. Although the ultimate objective of improved health care is a constant, the effective communication of product information is affected by a variety of factors which represent change or evolution. The discussion of drug information will review: the various forms that such information takes; the effects of differences in national health systems and objectives; and the implications of the fact that product data bases continue to develop after introductions. The systems and experience at the Upjohn Company, while not necessarily applicable for all companies, will be discussed briefly as useful examples of a working, effective process.</p>","PeriodicalId":51023,"journal":{"name":"Drug Information Journal","volume":"17 4","pages":"271-6"},"PeriodicalIF":0.0000,"publicationDate":"1983-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/009286158301700407","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Information Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/009286158301700407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

The ultimate responsibility and social contribution of the innovation-based pharmaceutical industry is to discover, develop, and provide products that contribute to improved health care. Achievement of this objective is dependent upon effective communication of accurate and comprehensive information about our products. This is a unique role which the research-based segment of the industry performs well and must be allowed to continue to perform. Although the ultimate objective of improved health care is a constant, the effective communication of product information is affected by a variety of factors which represent change or evolution. The discussion of drug information will review: the various forms that such information takes; the effects of differences in national health systems and objectives; and the implications of the fact that product data bases continue to develop after introductions. The systems and experience at the Upjohn Company, while not necessarily applicable for all companies, will be discussed briefly as useful examples of a working, effective process.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
创新医药产业在国际药品信息交流中的作用。
以创新为基础的制药业的最终责任和社会贡献是发现、开发和提供有助于改善卫生保健的产品。这一目标的实现依赖于准确和全面的产品信息的有效沟通。这是一个独特的角色,研究型行业表现良好,必须允许继续发挥作用。虽然改善医疗保健的最终目标是不变的,但产品信息的有效沟通受到代表变化或演变的各种因素的影响。药物信息的讨论将回顾:这些信息采取的各种形式;国家卫生系统和目标差异的影响;以及产品数据库在推出后继续发展这一事实的含义。厄普约翰公司的制度和经验虽然不一定适用于所有公司,但将作为有效工作过程的有用例子进行简要讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Information Journal
Drug Information Journal 医学-卫生保健
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊最新文献
Relative Efficiency of Unequal Versus Equal Cluster Sizes for the Nonparametric Weighted Sign Test Estimators in Clustered Binary Data. A Patient Focused Solution for Enrolling Clinical Trials in Rare and Selective Cancer Indications: A Landscape of Haystacks and Needles. Testing in a Prespecified Subgroup and the Intent-to-Treat Population. The Correction of Product Information in Drug References and Medical Textbooks Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1